These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18829568)

  • 21. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.
    Wang J; Sakariassen PØ; Tsinkalovsky O; Immervoll H; Bøe SO; Svendsen A; Prestegarden L; Røsland G; Thorsen F; Stuhr L; Molven A; Bjerkvig R; Enger PØ
    Int J Cancer; 2008 Feb; 122(4):761-8. PubMed ID: 17955491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Sakata M; Kitamura YH; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jun; 29(6):2235-7. PubMed ID: 19528487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.
    Schiapparelli P; Enguita-Germán M; Balbuena J; Rey JA; Lázcoz P; Castresana JS
    Oncol Rep; 2010 Nov; 24(5):1355-62. PubMed ID: 20878131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
    Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
    Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
    Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
    Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
    Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M
    BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.
    Tchoghandjian A; Baeza-Kallee N; Beclin C; Metellus P; Colin C; Ducray F; Adélaïde J; Rougon G; Figarella-Branger D
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S608-19. PubMed ID: 21989663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
    Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
    Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous phenotype of human glioblastoma: in vitro study.
    Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
    Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and regulation of AC133 and CD133 in glioblastoma.
    Campos B; Zeng L; Daotrong PH; Eckstein V; Unterberg A; Mairbäurl H; Herold-Mende C
    Glia; 2011 Dec; 59(12):1974-86. PubMed ID: 21901757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of the prominin 1 TATA-less main promoters and tissue specificity of their transcript content.
    Pleshkan VV; Vinogradova TV; Sverdlov ED
    Biochim Biophys Acta; 2008 Oct; 1779(10):599-605. PubMed ID: 18602031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.
    Zarkoob H; Taube JH; Singh SK; Mani SA; Kohandel M
    PLoS One; 2013; 8(5):e64169. PubMed ID: 23734191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
    Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
    J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
    Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD133 is a marker of bioenergetic stress in human glioma.
    Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
    PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
    Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
    Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
    Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
    Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells.
    Dong L; Qi N; Ge RM; Cao CL; Lan F; Shen L
    Neurosci Lett; 2010 Nov; 484(3):210-4. PubMed ID: 20800650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy.
    Mia-Jan K; Jung SY; Kim IY; Oh SS; Choi E; Chang SJ; Kang TY; Cho MY
    BMC Cancer; 2013 Mar; 13():166. PubMed ID: 23537343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.